Accordingly, tyrosinase-reactive hybrid Th1/17 cells differentiated ex vivo in the presence of Ex527 (Sirt1 inhibitor) displayed a lower anti-tumor activity than untreated cells in a murine melanoma model. This evidence concerns the gene SIRT1 and neoplasm.